首页 /科研细胞 /科研细胞 /科研细胞 /CEM/C1(人急性淋巴细胞白血病细胞)

CEM/C1(人急性淋巴细胞白血病细胞)

CBP60711

询 价
索取STR
产品描述
产品数据库
I. General information 
Synonyms: CEM/C1
Background: CEM/C1 is a camptothecin (CPT) resistant derivative of the human T cell leukemia cell line CCRF-CEM (see ATCC CCL-119). The cell line was selected and subcloned in 1991 for resistance to CPT.
Species: Homo sapiens, human
Tissue: peripheral blood
Disease: acute lymphoblastic leukemia
Gender: Caucasian,Female,4 years
Morphology: lymphoblast
Growth Mode: suspension
Doubling Time: 26 hrs
DNA Profile: Cobioer’s Cell Line Authentication Service
Culture Medium:

RPMI-1640 +10%FBS

CEM/C1完全培养基,# CBP60711M
We strongly suggest to purchase the complete medium from Cobioer.

Cryopreservation medium: 90%FBS+10%DMSO
Tumor Formation: Yes, in nude mice,(The cells form serially transplantable intercranial and subcutaneous tumors.)
Comments: This cell line exhibits cross resistance to both the water soluble (topotecan) and water insoluble (9-amino-CPT and 10,11-methylenedioxy-CPT) analogs of CPT.
CEM/C1 cells are approximately 31 fold less sensitive to CPT than the parental CEM cells.   CEM/C1 cells display atypical multidrug resistance (MDR) and altered topoisomerase I catalytic activity.
Resistance to CPT is stable for up to six months.
For more information, please contact Cobioer (4008-750-250).

药靶模型联系方式: 华东销售经理:18240630236 全国销售经理:18066071954
诊断标准品联系方式: 华东销售经理:15000320447 华北销售经理:18131625521 华南销售经理:13484295986 华中&西南销售经理:13871580511 全国销售经理:13484295986

扫二维码

立即提交